Literature DB >> 3753538

Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus.

S J Golombek, F Graus, K B Elkon.   

Abstract

Autoantibodies may play an important role in the pathogenesis of central nervous system (CNS) disease in systemic lupus erythematosus (SLE). We obtained cerebrospinal fluid (CSF) and, in some cases, sera from 19 SLE patients with CNS lupus and from 12 SLE patients without CNS lupus. Autoantibodies to saline soluble cellular antigens were detected in the CSF of lupus patients and reflected those present in the serum. These antibodies were distinct from the previously described antineuronal antibodies. Analysis of the fine specificities of the anti-saline soluble cellular antigen antibodies revealed that the antiribosomal P protein antibody was present in 4 of 4 patients with lupus psychosis and was enriched in the CSF of 1 patient. Sera containing antiribosomal P protein showed prominent cytoplasmic staining of human cortical neurons, as well as an epithelial cell substrate. These observations, together with the increase in intrathecal IgG synthesis detected in 71% of patients tested, suggest that several populations of antibodies may contribute to the enhanced immunologic activity in the CSF of CNS lupus patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3753538     DOI: 10.1002/art.1780290906

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  20 in total

Review 1.  Systemic lupus erythematosus.

Authors:  M S Klein-Gitelman; M L Miller
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

2.  Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies.

Authors:  L T Costallat; R M de Oliveira; M B Santiago; W Cossermelli; A M Samara
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

3.  Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies.

Authors:  R A Fields; W L Sibbitt; H Toubbeh; A D Bankhurst
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

4.  Antibodies to protein P in systemic lupus erythematosus.

Authors:  L S Teh; A E Bedwell; D A Isenberg; C Gordon; P Emery; P J Charles; M Harper; N Amos; B D Williams
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

5.  Central nervous system function in systemic lupus erythematosus.

Authors:  K Elkon; H Weissbach; N Brot
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

6.  Organic brain syndrome with psychosis as an initial manifestation of systemic lupus erythematosus in an elderly woman.

Authors:  M E Mavrikakis; L G Antoniades; J B Germanides; D Sotou; A Rassidakis
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

7.  Acquired C1 inhibitor deficiency associated with systemic lupus erythematosus affecting the central nervous system.

Authors:  S Nakamura; M Yoshinari; Y Saku; K Hirakawa; C Miishima; K Murai; K Tokiyama; M Fujishima
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

8.  Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus.

Authors:  A A Long; S D Denburg; R M Carbotte; D P Singal; J A Denburg
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

Review 9.  Diagnosis and pathogenesis of CNS lupus.

Authors:  A P van Dam
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

10.  C5a alters blood-brain barrier integrity in experimental lupus.

Authors:  Alexander Jacob; Bradley Hack; Eddie Chiang; Joe G N Garcia; Richard J Quigg; Jessy J Alexander
Journal:  FASEB J       Date:  2010-01-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.